BRAF and carcinoma: Activation of the second arm of the serrated neoplasia pathway, also driven by CpG island methylation of unspecified tumor-suppressor genes but not DNA-repair genes, may indicate progression to BRAF-mutant MSS carcinoma [46, 47].